We aimed to compare the General Movement Assessment (GMA) and the Alberta Infant Motor Scale (AIMS) in preterm infants for the prediction of cerebral palsy (CP) and neurodevelopmental delay (NDD). Additionally, we aimed to evaluate the diagnostic compatibility of the General Movement Optimality Score (GMOS), the Motor Optimality Score (MOS), and AIMS for detecting CP and NDD. Seventy-five preterm infants with gestational age (GA) 24-37 weeks were enrolled. Group 1 was composed of infants with 24-28 GA (n = 22); groups 2 and 3 consisted of infants with 29-32 GA weeks (n = 23) and 33-37 GA (n = 30) weeks, respectively. The infants were assessed during the writhing period, the fidgety period, and at 6-12 months of corrected age with GMOS, MOS, and AIMS, respectively. In the writhing period, a cramped-synchronized pattern was observed in 17 (22%) infants, whereas a poor repertoire pattern was observed in 34 (45%) infants. In the fidgety period of the 63 infants, 29 (46%) presented with fidgety movements absent. The MOS and AIMS scores of the infants in group 1 were significantly lower than the other groups, which were statistically significant (p = 0.004, p˂0.001). High and positive compatibility (Kappa coefficient: 0.709; p = 0.001) was found between AIMS and GMOS scores and between AIMS and MOS scores (Kappa coefficient: 0.804; p < 0.001). In all groups, a statistically significant association was found between total GMOS scores (p = 0.003) and the presence of fidgety movements (p = 0.003). GMOS, MOS, and AIMS were found to be associated with CP and NDD (p < 0.001). GMA is an important tool for the prediction of CP and NDD. The combined use of GMOS, MOS, and AIMS may guide the clinical practice for the valid and reliable diagnosis of CP and NDD.
This study aims to investigate the effects of the Robotic Hand Exoskeleton system on spasticity, motor control skills, activities of daily living, quality of life, and functional independence in stroke patients. A randomized controlled trial was conducted with 36 stroke patients aged 35-85, divided into two groups: conventional physiotherapy (n = 18) and robotic rehabilitation (n = 18). Evaluations included the Modified Ashworth Scale (MAS) for spasticity, Motor Activity Log 28 (MAL28) for daily activities, Frenchay Arm Test for motor control, and Stroke Impact Scale 3.0 (SIS 3.0) for quality of life and functional independence. Both groups received 15 treatment sessions over five weeks, with the robotic rehabilitation group additionally using a Robotic Hand Exoskeleton for 10 minutes per session. A significant improvement was observed in MAS (ES=0.092), MAL28, Frenchay Arm Test (ES=0.093), and SIS 3.0 (ES=0.01) scores after treatment (p < 0.05). However, no statistically significant differences were found between the groups (p > 0.05). Robotic hand rehabilitation improved motor function, daily activities, quality of life, and reduced spasticity, but showed no superiority over conventional physiotherapy. Both treatments demonstrated similar effectiveness, with robotic rehabilitation offering potential financial and time-saving benefits for healthcare providers.
21 December 2021 in Türk Fizyoterapi ve Rehabilitasyon Dergisi
Purpose: To evaluate the relationship between the sitting posture, sitting balance and upper extremity functions of children with Spina Bifida (SB). Methods: Thirty-one children with SB, and aged 5-18 years, were included the study. Their physical and clinical characteristics were recorded. Seated Postural Control Measure (SPCM), Pedalo® Balance Measurement System, Sitting Assessment for Children with Neuromotor Dysfunction (SACND), Modified Functional Reach Test (MFRT) and Jebsen-Taylor Hand Function Test (JTHFT) were used. Results: There was a significant correlation between JTHFT results and the other test results, i.e. Pedalo® (r = -0.478, p=0.007), SACND (r=0.399, p=0.026) and MFRT (r = -0.598, p
13 August 2024 in Journal of Evaluation in Clinical Practice